Collard Craig A 4
4 · HERON THERAPEUTICS, INC. /DE/ · Filed Jan 20, 2026
Insider Transaction Report
Form 4
Collard Craig A
DirectorChief Executive Officer
Transactions
- Exercise/Conversion
Common Stock
[F1]2026-01-19+13,797→ 536,921 total - Exercise/Conversion
Restricted Stock Units
[F2]2026-01-19−13,797→ 110,375 totalExercise: $0.00→ Common Stock (13,797 underlying)
Footnotes (2)
- [F1]Each restricted stock unit represents a contingent right to receive one share of common stock.
- [F2]The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (01/19/2024).
Signature
/s/Kathryn Lester Attorney-in-fact for Craig Collard|2026-01-20